Sirolimus for treatment of bronchial stenosis after lung transplantation

Sirolimus for treatment of bronchial stenosis after lung transplantation - Sirolimus for post-lung transplant bronchial stenosis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027912

Enrollment

Registered

2017-08-01

Start date

2017-07-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial stenosis after lung transplantation

Interventions

Administration of sirolimus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Post-lung transplant patients with recurrent bronchial stenosis after lung transplantation who need conventional treatment every 3 months

Exclusion criteria

Exclusion criteria: - Patients with past-history of bronchial anastomosis dehiscence - Patients with interstitial pneumonia or malignancy or delayed bronchial anastomosis healing - Post- single lung transplant patients for interstitial pneumonia - Patients in pregnancy or lactation - Patients who want to be pregnant

Design outcomes

Primary

Measure	Time frame
Prevention of recurrent bronchial stenosis	—

Countries

Japan

Contacts

Public ContactHisashi Oishi

Tohoku University Hospital Thoracic Surgery

hisashi.oishi.c7@tohoku.ac.jp08016676364

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026